论文部分内容阅读
近年来,不少学者应用链激酶(简称STK)作冠状动脉内或周围静脉内注射以治疗急性心肌梗塞(简称AMI)。认为STK可溶解冠状动脉内的血栓而使闭塞的血管再通,缺血的心肌得到再灌注,因此可以挽救部分濒死心肌,是治疗的一种有效方法。
In recent years, many scholars use streptokinase (referred to as STK) for intracoronary or peripheral intravenous injection for the treatment of acute myocardial infarction (AMI). It is considered that STK can dissolve the thrombus in the coronary artery and recanalize the occluded vessel, and the ischemic myocardium can be reperfused. Therefore, it can save part of the dying myocardium and is an effective method for treatment.